656: A phase III trial comparing vorozole (RIVIZOR™) versus aminoglutethimlde in the treatment of advanced postmenopausal breast cancer
- 30 September 1997
- journal article
- abstracts
- Published by Elsevier in European Journal Of Cancer
- Vol. 33, S148
- https://doi.org/10.1016/s0959-8049(97)85234-3
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: